Phase I and Randomized Phase II Study of Ruxolitinib With Frontline Neoadjuvant Therapy in Advanced Ovarian Cancer: An NRG Oncology Group Study. - Landen CN; Buckanovich RJ; Sill MW; Mannel RS; Walker JL; DiSilvestro PA; Mathews CA; Mutch DG; Hernandez ML; Martin LP; Bishop E; Gill SE; et al. (Journal of clinical oncology : official journal of the American Society of Clinical Oncology, 2024)